Company intelligence / Profile preview

Evidera

Bethesda, Maryland, USAevidera.com ↗

Ownership: Private
Employees: ~750
Development stage: Commercial

Overview

Evidera does not conduct its own clinical trials for proprietary drugs but has supported thousands of studies for biopharma clients. It specializes in generating real-world evidence and health economics data to support regulatory submissions and market access globally. The company has contributed to over 2,400 peer-reviewed publications and supported submissions to major HTA bodies such as NICE, CADTH, IQWiG, FDA, PBAC.[2]

Therapeutic areas: ImmunologyOncologyRare Diseases
Modalities: Cell therapyGene therapyBiologicSmall moleculeVaccine
Industry: Contract Research Organization

Beyond the preview

Go deeper on Evidera.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Evidera.

Explore the full profile